Bio

Brandon Dalziel represents business clients in matters involving health care, corporate and commercial law, including corporate organization, mergers and acquisitions, and other commercial transactions. He has represented a wide range of health care industry clients in complex transactions. Representative transactions include: numerous hospital member substitutions with hospital systems, the sale and purchase of medical, dental and other healthcare practices of varying size and complexity, management agreements (including to address corporate practice of medicine implications), joint ventures, and other arrangements. Mr. Dalziel also provides counseling and guidance on regulatory matters, including fraud and abuse (including anti-kickback and Stark law), HIPAA (including the reporting of breaches), as well as a wide range of contractual matters, corporate organization and charter document matters, the development and updating of policies and procedures, and other day-to-day and long-term matters. He is the Chair of Bodman’s Health Care Practice Group. Mr. Dalziel has been named a 2024 “Top Lawyer” in Health Care Law by DBusiness magazine. He is listed in Michigan Super Lawyers 2022 under Health Care Law. He serves on the Board of Directors of the Notre Dame Club of Detroit. Before joining Bodman, Mr. Dalziel managed clinical studies and integrated genetics into drug development with Pfizer Global Research & Development in Ann Arbor. In law school, Mr. Dalziel interned with Hon. John Corbett O’Meara of the United States District Court for the Eastern District of Michigan and was a member of the Intellectual Property Organization.